首页> 中文期刊> 《临床医药实践》 >SELDI-TOF-MS 技术预测癌痛发生的研究之一--采用 SELDI-TOF-MS 技术捕获癌痛的指纹标记〔1〕

SELDI-TOF-MS 技术预测癌痛发生的研究之一--采用 SELDI-TOF-MS 技术捕获癌痛的指纹标记〔1〕

         

摘要

Objective:To capture the fingerprint marker of advanced malignant neoplasm when pain occurs. Methods:Chose 24 patients with advanced malignant neoplasm confirmed by pathology or cytology,collected peripheral venous blood on an empty stomach,followed up till three months later,they were divided into 2 groups according to the pain occurrence,pain group(9 cases)and painless group(15 cases),by SELDI - TOF - MS(surface - enhanced laser desorption/ ionization time -of - flight mass spectrometry)technique and CM10 proteinchip,these serum proteomic fingerprints were memorized. Results:There were 6 significant different protein fingerprints between painless and pain group,M/ Z values were 2 755,8 678,8 813, 11 361,11 447,11 605. Compared with painless group,M/ Z2755,11 361,11 447,11 605 were up - regulated expressed,and 8 678,8 813 down - regulated expressed. We draw the following results from further analysis:M/ Z 2 755,8 678,8 813 were pres-ent between the two groups,the median value was 6,2,3 in the pain group,and 2,6,10 in the painless group. In addtion,M/ Z 11 361,11 447,11 605 in positive expression of pain,painless group were negative. Conclusion:The protein fingerprints of M/Z2755 high protein expression,M/ Z8 678,8 813 lower expression,M/ Z11 361,11 447,11 605 positive expression can exist as the special fingerprint marker of cancer pain.%目的:借助表面增强激光解吸电离飞行时间质谱(SELDI - TOF - MS)技术捕获晚期恶性肿瘤癌痛发生时的指纹标记。方法:选择24例经病理学或细胞学确诊的晚期恶性肿瘤患者,清晨采集空腹末梢静脉血,采血后观察3个月。将3个月内发生癌痛的患者的血清样本归为癌痛组(9例),3个月内未发生癌痛的血清样本归为无痛组(15例),应用 CM10弱阳离子芯片结合 SELDI - TOF - MS 技术检测两组患者血清样本的蛋白质谱。结果:无痛组与癌痛组相比有6个蛋白质峰的差异有统计学意义( P ﹤0.05),蛋白质质荷比( M / Z)分别为2755,8678,8813,11361,11447,11605。其中与无痛组相比,癌痛组上调的峰 M/ Z 为2755,11361,11447,11605,下调的峰 M/ Z 为8678和8813。进一步对所有患者的蛋白质指纹图谱进行分析,得出:M/ Z 为2755,8678,8813的蛋白质组在两组之间都存在,癌痛组其丰度中位值分别为6,2,3,无痛组中其丰度中位值分别为2,6,10,而 M/ Z 为11361,11447,11605在癌痛组中呈阳性表达,无痛组则呈阴性表达。结论:蛋白质 M/ Z 2755高表达,M/ Z 8678,8813低表达,M/ Z 11361,11447,11605呈阳性表达,可以作为癌痛发生的特异指纹标记。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号